• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addition of omalizumab to antihistamine treatment in chronic urticaria: A real-world study in China.

作者信息

Chen Yu-Di, Maurer Marcus, Yu Miao, Tu Ping, Zhao Zuo-Tao

机构信息

Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.

Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy Charité-Universitatsmedizin Berlin, Berlin, Germany.

出版信息

Ann Allergy Asthma Immunol. 2020 Aug;125(2):217-219. doi: 10.1016/j.anai.2020.04.026. Epub 2020 May 1.

DOI:10.1016/j.anai.2020.04.026
PMID:32371240
Abstract
摘要

相似文献

1
Addition of omalizumab to antihistamine treatment in chronic urticaria: A real-world study in China.奥马珠单抗联合抗组胺药治疗慢性荨麻疹：一项中国的真实世界研究。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):217-219. doi: 10.1016/j.anai.2020.04.026. Epub 2020 May 1.
2
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU.抗核抗体很常见，且与慢性自发性荨麻疹患者对奥马珠单抗治疗反应不佳有关。
Allergy. 2020 Feb;75(2):468-470. doi: 10.1111/all.14033. Epub 2019 Oct 3.
3
Use of omalizumab in uncontrolled chronic spontaneous urticaria also improved latex-induced contact urticaria.在控制不佳的慢性自发性荨麻疹中使用奥马珠单抗也改善了乳胶诱导的接触性荨麻疹。
J Allergy Clin Immunol Pract. 2019 Jan;7(1):300-302. doi: 10.1016/j.jaip.2018.05.005. Epub 2018 May 23.
4
Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.奥马珠单抗单药或联合治疗慢性自发性荨麻疹的有效性和安全性的真实世界数据：一项回顾性队列研究。
J Dermatolog Treat. 2020 Mar;31(2):204-209. doi: 10.1080/09546634.2019.1589639. Epub 2019 Mar 7.
5
Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria.奥马珠单抗治疗与慢性诱导性荨麻疹相关的慢性自发性荨麻疹的疗效
Ann Allergy Asthma Immunol. 2020 Oct;125(4):486-487. doi: 10.1016/j.anai.2020.06.011. Epub 2020 Jun 13.
6
[Translated article] Use of Antihistamines During Omalizumab Therapy in Chronic Urticaria in the Routine Clinical Practice. A 48-Patient Observational Trial.[翻译文章] 奥马珠单抗治疗慢性荨麻疹期间在常规临床实践中使用抗组胺药。一项48例患者的观察性试验。
Actas Dermosifiliogr. 2024 Jun;115(6):T636-T638. doi: 10.1016/j.ad.2024.04.012. Epub 2024 Apr 20.
7
Efficacy of drug therapies in antihistamine refractory chronic spontaneous urticaria: Real life data.抗组胺药难治性慢性自发性荨麻疹药物治疗的疗效：真实世界数据。
Asian Pac J Allergy Immunol. 2024 Jun;42(2):138-146. doi: 10.12932/AP-270820-0948.
8
The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort.在西澳大利亚门诊队列中，奥马珠单抗治疗难治性慢性自发性荨麻疹的应用。
Intern Med J. 2019 Apr;49(4):526-528. doi: 10.1111/imj.14245.
9
Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.血液学参数作为慢性自发性荨麻疹对抗组胺药和奥马珠单抗耐药的生物标志物。
Allergy Asthma Proc. 2021 Jan 1;42(1):e17-e24. doi: 10.2500/aap.2021.42.200088.
10
A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.一项奥马珠单抗治疗慢性自发性荨麻疹患者的回顾性分析：比利时真实世界研究。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):127-134. doi: 10.1111/jdv.15684. Epub 2019 Aug 19.

引用本文的文献

1
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?影响慢性荨麻疹患者接受奥马珠单抗治疗后复发的因素。停药方法是否会影响复发？
Dermatol Pract Concept. 2025 Jul 31;15(3):5196. doi: 10.5826/dpc.1503a5196.
2
Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome.奥马珠单抗治疗慢性自发性荨麻疹：一项关于有效性、安全性及治疗结果预测因素的真实世界研究
Clin Cosmet Investig Dermatol. 2024 Aug 7;17:1799-1808. doi: 10.2147/CCID.S470160. eCollection 2024.
3
Expert consensus on the use of omalizumab in chronic urticaria in China.
中国奥马珠单抗治疗慢性荨麻疹专家共识
World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov.
4
The Emerging Role of Mast Cells in Response to Fungal Infection.肥大细胞在真菌感染反应中的新作用。
Front Immunol. 2021 Jun 3;12:688659. doi: 10.3389/fimmu.2021.688659. eCollection 2021.
5
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.奥马珠单抗治疗中国慢性自发性荨麻疹、慢性诱导性荨麻疹或两者皆有的患者及其疗效
World Allergy Organ J. 2021 Jan 5;14(1):100501. doi: 10.1016/j.waojou.2020.100501. eCollection 2021 Jan.